Invention Grant
- Patent Title: Spirothietane nucleosides
-
Application No.: US16641209Application Date: 2018-08-31
-
Publication No.: US11267844B2Publication Date: 2022-03-08
- Inventor: Abdellah Tahri , Jean-François Bonfanti , Tim Hugo Maria Jonckers , Pierre Jean-Marie Bernard Raboisson
- Applicant: Janssen Pharmaceutica NV
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE Beerse
- Agent Sofia Kopelevich
- Priority: EP17189097 20170901
- International Application: PCT/EP2018/073505 WO 20180831
- International Announcement: WO2019/043177 WO 20190307
- Main IPC: C07H19/06
- IPC: C07H19/06 ; C07H19/10 ; C07H19/16 ; C07H19/20 ; A61P31/14 ; A61K45/06

Abstract:
The present invention relates to 2′-spirothietane nucleosides, and the phosphates and the prodrugs thereof, and the pharmaceutically acceptable salts and solvates thereof, and the use of such compounds as a medicament, in particular in the prevention and/or treatment of viral infections caused by viruses belonging to the Flaviviridae family and/or to the alphavirus genus. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the compounds, and to the compositions or preparations for use as a medicament, more preferably for the prevention or treatment of viral infections caused by viruses belonging to the Flaviviridae family and/or to the alphavirus genus. The invention also relates to processes for the preparation of the compounds.
Public/Granted literature
- US20210139524A1 SPIROTHIETANE NUCLEOSIDES Public/Granted day:2021-05-13
Information query
IPC分类: